A 4852 NJ
Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →
Sponsors (7)
- Katz, Andrea Democratic · primary
- Sweeney, Marisa · primary
- Kearney, Vincent M. · primary
- Tully, Chris Democratic · primary
- Vitale, Joseph F. Democratic · primary
- Gopal, Vin Democratic · primary
- Mukherji, Raj Democratic · primary
2 coauthors / cosponsors
- Karabinchak, Robert J. Democratic · cosponsor
- Donlon, Margie, M.D. · cosponsor
Action history (8)
- May 4, 2026 Introduced, Referred to Assembly Health Committee · lower
- Jun 23, 2026 Transferred to Assembly State and Local Government Committee · lower
- Jun 23, 2026 Reported from Assembly Comm. as a Substitute, 2nd Reading · lower
- Jun 30, 2026 Passed by the Assembly (76-2-1) · lower
- Jun 30, 2026 Received in the Senate without Reference, 2nd Reading · upper
- Jun 30, 2026 Substituted for S4194/4210 (SCS) · lower
- Jun 30, 2026 Passed Senate (Passed Both Houses) (38-2) · upper
- Jul 8, 2026 Approved P.L.2026, c.40. · lower
Full text
The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.
Comments
Data from OpenStates. View on OpenStates →
Comments